Vir Biotechnology Director SATO VICKI L Sells 22000 Shares at $4.99/Share.

Vir Biotechnology, Inc. recently disclosed that Director SATO VICKI L has executed a transaction involving the sale of 22,000 shares at a price of $4.99 per share on August 1, 2025.

Vir Biotechnology, Inc. (VIR) has experienced a series of market fluctuations, with its stock price dropping by 0.789% on August 1, 2025, closing at $5.03. This decline follows a downward trend that has seen the stock fall for seven consecutive days [1]. The stock price has decreased by 7.02% over the last ten trading days, with a significant drop of 15.18% since a pivot top point on July 10, 2025 [1].

On the same day, Director SATO VICKI L executed a transaction by selling 22,000 shares at $4.99 per share. This transaction, although not indicative of the overall market sentiment, could be seen as a strategic move by the director, potentially signaling a cautious outlook on the stock's performance [2].

The stock's recent performance indicates several technical sell signals, including negative Moving Average Crossovers and a sell signal from the 3-month MACD. Additionally, the stock is trading within a wide and weak rising trend, which could suggest a potential buying opportunity if the lower trend floor at $4.89 is broken [1].

Looking ahead, the stock is expected to rise by 8.03% over the next three months, with a predicted price range between $5.28 and $6.53 [1]. However, given the current negative signals, the stock is not recommended for immediate purchase.

For the upcoming trading day on August 4, 2025, the stock is expected to open at $4.99, with a possible range of $4.90 to $5.16, indicating a potential swing of up to 5.49% during the day [1].

References:

[1] https://stockinvest.us/stock/VIR
[2] Internal Company Filings, August 1, 2025